Healthcare provider profile · identity verified

Lindy Allison Taylor, MD

General Practice · PORT RICHEY, FL · NPI 1962482117

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	345	54
Gabapentin	Gabapentin	332	72
Atorvastatin Calcium	Atorvastatin Calcium	300	53
Trazodone Hcl	Trazodone Hcl	298	49
Lisinopril	Lisinopril	297	47
Quetiapine Fumarate	Quetiapine Fumarate	221	34
Omeprazole	Omeprazole	208	33
Sertraline Hcl	Sertraline Hcl	182	33
Amlodipine Besylate	Amlodipine Besylate	174	35
Pantoprazole Sodium	Pantoprazole Sodium	157	27
Potassium Chloride	Potassium Chloride	157	32
Donepezil Hcl	Donepezil Hcl	138	25
Metoprolol Tartrate	Metoprolol Tartrate	138	31
Furosemide	Furosemide	134	31
Mirtazapine	Mirtazapine	129	33
Metoprolol Succinate	Metoprolol Succinate	125	26
Rosuvastatin Calcium	Rosuvastatin Calcium	124	20
Escitalopram Oxalate	Escitalopram Oxalate	118	19
Famotidine	Famotidine	118	20
Eliquis	Apixaban	115	19
Losartan Potassium	Losartan Potassium	110	26
Meloxicam	Meloxicam	109	24
Metformin Hcl	Metformin Hcl	105	17
Memantine Hcl	Memantine Hcl	104	19
Prednisone	Prednisone	104	47
Tamsulosin Hcl	Tamsulosin Hcl	95	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	92	15
Tizanidine Hcl	Tizanidine Hcl	90	28
Clopidogrel	Clopidogrel Bisulfate	87	21
Alprazolam	Alprazolam	83	25
Divalproex Sodium	Divalproex Sodium	77	16
Duloxetine Hcl	Duloxetine Hcl	73	14
Carvedilol	Carvedilol	72	15
Baclofen	Baclofen	68	suppressed
Spironolactone	Spironolactone	68	15
Simvastatin	Simvastatin	65	suppressed
Trulicity	Dulaglutide	63	suppressed
Cephalexin	Cephalexin	62	35
Fluticasone Propionate	Fluticasone Propionate	59	11
Hydrochlorothiazide	Hydrochlorothiazide	58	11
Jardiance	Empagliflozin	56	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	54	suppressed
Ezetimibe	Ezetimibe	54	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	53	25
Hydrocortisone	Hydrocortisone	52	suppressed
Bupropion Xl	Bupropion Hcl	49	suppressed
Tramadol Hcl	Tramadol Hcl	49	26
Alendronate Sodium	Alendronate Sodium	48	suppressed
Januvia	Sitagliptin Phosphate	48	suppressed
Hydralazine Hcl	Hydralazine Hcl	47	suppressed
Lorazepam	Lorazepam	47	19
Fluoxetine Hcl	Fluoxetine Hcl	46	suppressed
Ibuprofen	Ibuprofen	45	13
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	45	suppressed
Celecoxib	Celecoxib	44	suppressed
Montelukast Sodium	Montelukast Sodium	44	suppressed
Buspirone Hcl	Buspirone Hcl	43	suppressed
Nifedipine Er	Nifedipine	43	suppressed
Levetiracetam	Levetiracetam	42	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	41	30
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	41	34
Xarelto	Rivaroxaban	41	suppressed
Atenolol	Atenolol	39	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Risperidone	Risperidone	38	suppressed
Allopurinol	Allopurinol	37	suppressed
Finasteride	Finasteride	37	suppressed
Fluconazole	Fluconazole	37	23
Myrbetriq	Mirabegron	35	suppressed
Propranolol Hcl	Propranolol Hcl	35	suppressed
Desmopressin Acetate	Desmopressin Acetate	34	suppressed
Liothyronine Sodium	Liothyronine Sodium	32	suppressed
Bumetanide	Bumetanide	31	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Benztropine Mesylate	Benztropine Mesylate	30	suppressed
Clonidine Hcl	Clonidine Hcl	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Amantadine	Amantadine Hcl	29	suppressed
Azithromycin	Azithromycin	29	26
Olanzapine	Olanzapine	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	27	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	27	18
Ondansetron Hcl	Ondansetron Hcl	27	13
Oxcarbazepine	Oxcarbazepine	27	suppressed
Pentoxifylline	Pentoxifylline	27	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	26	suppressed
Clonazepam	Clonazepam	26	suppressed
Incruse Ellipta	Umeclidinium Bromide	26	suppressed
Trintellix	Vortioxetine Hydrobromide	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Memantine Hcl Er	Memantine Hcl	25	suppressed
Topiramate	Topiramate	24	suppressed
Loperamide	Loperamide Hcl	23	11
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Nystatin	Nystatin	22	12
Ozempic	Semaglutide	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	17
Aripiprazole	Aripiprazole	20	suppressed
Primidone	Primidone	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Carbamazepine	Carbamazepine	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Cefdinir	Cefdinir	17	14
Latanoprost	Latanoprost	17	suppressed
Temazepam	Temazepam	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	14
Entresto	Sacubitril/Valsartan	16	suppressed
Humalog	Insulin Lispro	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Albuterol Sulfate	Albuterol Sulfate	15	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	15	suppressed
Diltiazem Hcl	Diltiazem Hcl	15	suppressed
Glipizide	Glipizide	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Rivastigmine	Rivastigmine	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Calcitriol	Calcitriol	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Naltrexone Hcl	Naltrexone Hcl	14	suppressed
Verapamil Hcl	Verapamil Hcl	14	suppressed
Zonisamide	Zonisamide	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Enulose	Lactulose	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Levocarnitine	Levocarnitine (With Sugar)	13	suppressed
Norgestimate-Ethinyl Estradiol	Norgestimate-Ethinyl Estradiol	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Westab Plus	Pnv,calcium 72/Iron/Folic Acid	13	suppressed
Diazepam	Diazepam	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Lactulose	Lactulose	12	suppressed
Levofloxacin	Levofloxacin	12	12
Mupirocin	Mupirocin	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Lithium Carbonate	Lithium Carbonate	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Permethrin	Permethrin	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error